#POC Blood Glucose Monitoring Devices Market Share

[businessmarketreports]

An Overview of POC Analyzers Market: Trends and Insights

The Point-of-Care (POC) analyzers market is rapidly expanding, driven by advances in medical technology, a shift towards decentralization of healthcare, and an increasing demand for quick, accurate diagnostic results.

Buy the Full Report for More Insights on the Point of Care Analyzers Market Forecast

Download a Free Sample Report

These devices enable healthcare professionals to conduct diagnostic tests at or near the site of patient care, reducing the time to diagnosis and improving treatment outcomes. POC analyzers are used in various settings, including hospitals, clinics, emergency rooms, home care, and remote healthcare facilities.

1. Market Size and Growth

Market Value (2024): The global POC analyzers market is expected to reach approximately USD 50 billion by 2024, with a CAGR of 8-10% from 2024 to 2030.

Key Segments:

Blood Gas and Electrolytes Analyzers

Glucose Monitoring Systems

Infectious Disease Testing

Pregnancy and Fertility Testing

Cardiac Biomarker Testing

Other Specialty Tests (e.g., HIV, flu, diabetes)

2. Key Market Trends

a. Increasing Demand for Rapid Diagnostics

POC analyzers are gaining traction due to the growing need for faster, on-the-spot diagnostic results in critical care and emergency settings.

COVID-19 accelerated the adoption of rapid tests, highlighting the importance of POC testing in managing infectious diseases.

b. Technological Advancements

Continuous innovations in miniaturization, portability, and ease of use are improving the efficiency and performance of POC analyzers.

Integration of smart technologies, such as cloud connectivity, mobile applications, and AI, is enabling real-time data sharing, remote monitoring, and better decision-making.

c. Increasing Prevalence of Chronic Diseases

The growing global burden of chronic diseases, including diabetes, cardiovascular conditions, and respiratory diseases, is driving the demand for frequent and personalized monitoring through POC devices.

d. Home Healthcare and Remote Monitoring

There is a rise in home healthcare and self-testing, driven by an aging population and increased awareness of health management. POC analyzers for at-home use, like glucose meters and cholesterol monitors, are becoming more popular.

Telehealth integration with POC analyzers is emerging as a key trend, enabling remote consultations and real-time diagnostics.

e. Growing Focus on Patient-Centric Healthcare

The move towards patient-centric models, where patients take a more active role in managing their health, is fueling the demand for easy-to-use and accessible POC analyzers.

3. Market Drivers

a. Rising Healthcare Costs

POC testing helps reduce overall healthcare costs by enabling early diagnosis and preventing unnecessary hospital visits, readmissions, and extended stays.

b. Decentralization of Healthcare

With the growing focus on decentralized healthcare, particularly in rural or underserved areas, POC analyzers are becoming vital tools for enabling diagnosis and treatment outside traditional hospital settings.

c. Favorable Government Initiatives

Governments worldwide are increasingly supporting POC testing through favorable reimbursement policies, making them more accessible to healthcare providers and patients.

d. Technological Innovations

Advances in biosensors, nanotechnology, and microfluidics are enabling the development of more accurate, compact, and affordable POC diagnostic solutions.

4. Key Challenges

a. Regulatory and Quality Control Concerns

POC analyzers, especially those for use at home, face stringent regulatory scrutiny to ensure accuracy, reliability, and safety. Regulatory hurdles may delay product approval and market entry.

b. Limited Reimbursement in Some Regions

In some regions, reimbursement for POC tests is not as comprehensive as for traditional lab tests, which can limit adoption.

c. Data Privacy and Security Issues

With the rise of cloud-based solutions and digital integration, data privacy concerns are becoming increasingly important, especially in healthcare settings.

d. High Initial Costs

While POC analyzers reduce long-term healthcare costs, the upfront cost of these devices may be prohibitive for some smaller healthcare providers and individuals, especially in low-income regions.

5. Market Segmentation

a. By Type of Test

Blood Gas and Electrolytes Analyzers: Used in emergency departments and intensive care units (ICUs) for rapid blood analysis, these analyzers help detect critical conditions such as respiratory or metabolic imbalances.

Glucose Monitoring Systems: Widely used by individuals with diabetes, glucose meters and continuous glucose monitoring systems are a key driver of the POC market.

Cardiac Biomarker Testing: POC analyzers are commonly used for cardiac markers like troponin to diagnose heart attacks and other cardiovascular conditions.

Infectious Disease Testing: Tests for diseases like HIV, influenza, and COVID-19 are increasingly available as POC diagnostics.

b. By End User

Hospitals and Clinics: The largest segment, driven by the need for quick diagnostics in high-pressure settings like emergency rooms and intensive care units.

Home Care Settings: Rapid growth in home care and self-testing for chronic conditions like diabetes, blood pressure, and cholesterol.

Ambulatory Care Centers and Diagnostic Laboratories: These facilities are adopting POC analyzers for their flexibility and ability to deliver results quickly.

c. By Technology

Biosensors: Used for various POC devices, including glucose meters and cardiac markers.

Microfluidics: Widely used in portable diagnostics for fluid-based analysis.

Immunoassays and Molecular Diagnostics: Employed for infectious disease testing and personalized medicine.

6. Competitive Landscape

a. Key Players

Abbott Laboratories – One of the leading companies in the POC market, known for its glucose monitoring systems and COVID-19 rapid tests.

Siemens Healthineers – Provides a broad range of POC analyzers, including blood gas analyzers, molecular diagnostics, and point-of-care immunoassay systems.

Roche Diagnostics – A prominent player with a strong portfolio in infectious disease testing and molecular diagnostics at the point of care.

Thermo Fisher Scientific – Known for offering POC testing solutions, particularly in molecular diagnostics and infectious diseases.

Quidel Corporation – A key player in rapid infectious disease testing, including flu and COVID-19 diagnostics.

b. Recent Developments

Abbott continues to innovate in molecular diagnostics, focusing on portable testing solutions for infectious diseases.

Roche has expanded its POC offerings in the immunoassay space, making diagnostic testing faster and more accessible in hospital and outpatient settings.

7. Regional Insights

North America: Dominates the global market due to the high adoption rate of advanced technologies and strong healthcare infrastructure. The U.S. is a key market for POC diagnostics, driven by aging populations and increasing chronic disease prevalence.

Europe: Shows strong growth, particularly in infectious disease testing and the aging demographic.

Asia-Pacific: The fastest-growing region, driven by large populations, increasing healthcare access, and growing healthcare needs in emerging economies like China and India.

Latin America & Middle East & Africa: These regions are expected to experience steady growth, especially in point-of-care testing for infectious diseases and chronic conditions.

8. Future Outlook

The POC analyzers market is poised for continued growth as healthcare systems worldwide move towards more efficient, decentralized care models. Innovations in miniaturization, AI, and connectivity will enable more sophisticated and user-friendly devices. Additionally, as governments and healthcare providers focus on improving access to healthcare, especially in remote and underserved regions, POC analyzers will play a critical role in expanding diagnostic capabilities globally.

The ongoing shift towards home healthcare, increasing demand for chronic disease management, and the rise of telemedicine and remote monitoring will further drive market expansion in the coming years.

[credenceresearchdotblog]

The global demand for Point-Of-Care Diagnostics / Testing (POCT) was valued at USD 45618.5 Million in 2023 and is expected to reach USD 118599.8 Million in 2032, growing at a CAGR of 11.20% between 2024 and 2032.The Point-of-Care (POC) diagnostics/testing market has emerged as a transformative force in healthcare, promising to deliver rapid and accurate diagnostic results at the patient's bedside or near the site of care. This market is experiencing significant growth due to technological advancements, rising prevalence of chronic diseases, and the increasing need for rapid diagnostics in remote and resource-limited settings.

Browse the full report at https://www.credenceresearch.com/report/point-of-care-diagnostics-or-testing-market

Introduction to Point-of-Care Diagnostics

Point-of-care diagnostics refers to medical diagnostic testing performed outside the traditional laboratory setting, typically at or near the site of patient care. These tests enable healthcare providers to make immediate clinical decisions, thus improving patient outcomes and streamlining the care process. POC diagnostics encompass a broad range of tests, including blood glucose monitoring, pregnancy tests, infectious disease detection, and cholesterol testing, among others.

Market Dynamics

Technological Advancements: The rapid advancements in technology have been a key driver of the POC diagnostics market. Innovations such as microfluidics, lab-on-a-chip technology, and portable diagnostic devices have made it possible to conduct complex tests with minimal sample volumes and faster turnaround times. These technologies not only enhance the accuracy and reliability of POC tests but also make them more accessible and user-friendly.

Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases has fueled the demand for POC diagnostics. These conditions require continuous monitoring and timely interventions, which POC tests can provide. For instance, the global rise in diabetes cases has led to a surge in demand for blood glucose monitoring devices.

Need for Rapid Diagnostics in Remote Areas: In many parts of the world, particularly in low- and middle-income countries, access to centralized laboratory facilities is limited. POC diagnostics bridge this gap by providing essential diagnostic services in remote and resource-limited settings. This capability is crucial for managing infectious diseases and other health conditions in areas with limited healthcare infrastructure.

Key Market Segments

The POC diagnostics market is segmented based on product type, technology, end-user, and region.

Product Type: The market includes a variety of POC testing products such as glucose monitoring kits, infectious disease testing kits, pregnancy and fertility testing kits, cholesterol testing kits, hematology testing kits, and others. Among these, glucose monitoring kits hold a significant share due to the high prevalence of diabetes.

Technology: Based on technology, the market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. Lateral flow assays are widely used due to their simplicity, low cost, and rapid results.

End-User: The end-users of POC diagnostics include hospitals and clinics, home care settings, diagnostic centers, and research laboratories. Hospitals and clinics are the major end-users due to the high volume of patients and the need for rapid diagnostic results.

Region: Geographically, the market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America holds the largest market share due to advanced healthcare infrastructure, high adoption of new technologies, and the presence of major market players. However, the Asia-Pacific region is expected to witness the highest growth rate due to increasing healthcare expenditure, growing awareness about POC diagnostics, and improving healthcare facilities.

Challenges and Future Prospects

Despite the promising growth, the POC diagnostics market faces several challenges. These include regulatory hurdles, the high cost of advanced diagnostic devices, and issues related to the accuracy and reliability of some POC tests. Moreover, there is a need for greater integration of POC diagnostic data with electronic health records to ensure seamless patient care.

Looking ahead, the POC diagnostics market is poised for substantial growth, driven by continuous technological advancements, increasing healthcare needs, and the ongoing efforts to improve access to quality healthcare services worldwide. The integration of artificial intelligence and machine learning in POC diagnostics is expected to further enhance diagnostic accuracy and personalized patient care.

Key Players

Abbott (U.S.)

F. Hoffmann-La Roche Ltd (Switzerland)

B.D. (U.S.)

Siemens Healthcare Private Limited (Germany)

Bio-Rad Laboratories, Inc. (U.S.)

Danaher (U.S.)

Sekisui Diagnostics (U.S.)

Trinity Biotech (Ireland)

bioMérieux (France)

EKF Diagnostics (Germany)

AccuBioTech Co., Ltd. (China)

Instrumentation Laboratory (U.S.)

Beckman Coulter, Inc. (U.S.)

PTS Diagnostics (U.S.)

Nova Biomedical (U.S.)

Chembio Diagnostics, Inc. (U.S.)

Quidel Corporation (U.S.)

Sienco, Inc (U.S.)

Segmentation

By Technology:

Lateral Flow Assays (LFAs)

Dipsticks

Microfluidics/ Lab-on-a-Chip (LOC)

Biosensors

Molecular Diagnostics

Immunodiagnostics

Hematology Analyzers

Coagulation Monitoring

Others

By End-User:

Hospitals and Clinics

Physician Offices

Ambulatory Care Settings

Home Care

Diagnostic Laboratories

Research Institutes

By Application:

Infectious Disease Testing

HIV

Influenza

Hepatitis

Sexually Transmitted Infections (STIs)

Others

Cardiology

Diabetes Monitoring

Coagulation Monitoring

Pregnancy and Fertility Testing

Cancer Markers

Urinalysis

Cholesterol Testing

Others

By Product Type:

Blood Glucose Monitoring Kits

Cardiac Marker Testing Kits

Infectious Disease Testing Kits

Pregnancy and Fertility Testing Kits

Hematology Testing Kits

Coagulation Testing Kits

Cholesterol Testing Kits

Urinalysis Testing Kits

Drug-of-Abuse Testing Kits

Others

By Platform:

Desktop/ Benchtop Analyzers

Handheld/ Portable Analyzers

By Distribution Channel:

Hospitals and Clinics

Pharmacies

Online Retailers

Diagnostic Centers

By Infectious Disease Testing Type:

HIV POCT

Influenza POCT

Hepatitis POCT

Sexually Transmitted Infections (STIs) POCT

Others

By Cardiac Marker Testing Type:

Troponin Testing

BNP Testing

Others

By Pregnancy and Fertility Testing Type:

Pregnancy Testing Kits

Ovulation Prediction Kits

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/point-of-care-diagnostics-or-testing-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[trendtrackershq]

Asia-Pacific: A Rising Giant - Poised for Dominance in the Point-of-Care Glucose Testing Market by 2030

Introduction:

The Point-of-Care Glucose Testing Market is experiencing a global surge, driven by the rising diabetes epidemic and the increasing demand for convenient and self-monitoring blood sugar management tools. While North America currently holds the dominant market share, the Asia-Pacific (APAC) region is emerging as a strong contender, poised for significant growth in the coming years.

Download FREE Sample: https://www.nextmsc.com/point-of-care-glucose-testing-market/request-sample

A Growing Diabetes Burden: Fueling Demand for POC Testing

The APAC region faces a significant challenge with a rapidly rising diabetes burden. According to the International Diabetes Federation (IDF), the APAC region is home to over half of the world's diabetic population, with China and India leading the charge [Source 2]. This alarming statistic underscores the urgent need for accessible and efficient blood sugar monitoring solutions, making POC glucose testing devices highly sought-after in the region.

Factors Driving Growth in the APAC POC Glucose Testing Market:

Several key factors are contributing to the exponential growth of the APAC POC glucose testing market:

Rising Disposable Incomes and Growing Awareness: The economic growth witnessed in several APAC countries is leading to increased disposable incomes. This, coupled with growing awareness about diabetes and its management, is creating a favorable environment for the adoption of POC glucose testing devices.

Expanding Healthcare Infrastructure and Government Initiatives: Governments in the APAC region are making significant investments in expanding healthcare infrastructure, particularly in rural and remote areas. Additionally, several governments are implementing initiatives to promote diabetes screening and early detection. These initiatives often include promoting the use of POC glucose testing devices for effective self-monitoring.

Focus on Affordable and Accessible Technologies: Manufacturers are increasingly developing cost-effective POC glucose testing devices specifically tailored for the needs of the APAC market. This focus on affordability, alongside initiatives promoting access to these devices, is crucial for reaching a wider population in the region.

Technological Advancements and Mobile Health Integration: The APAC region is witnessing a rapid rise in mobile phone adoption and internet penetration. This opens doors for the integration of POC glucose testing devices with mobile health (mHealth) applications. These apps allow for data tracking, analysis, and remote consultations with healthcare providers, further enhancing the appeal and effectiveness of POC testing in the region.

Rise of Big Data and Analytics:  The vast amount of data generated by POC glucose testing devices, coupled with big data analytics, can provide valuable insights into diabetes trends and personalized treatment plans. This trend is likely to drive the adoption of POC devices with data connectivity capabilities in the APAC region.

Focus on Artificial Intelligence (AI) Integration:  Advancements in AI hold immense potential for the POC glucose testing market. AI-powered algorithms can analyze blood sugar data and identify trends, predict potential complications, and even offer personalized recommendations for diabetes management. This integration of AI with POC devices is expected to gain traction in the APAC region.

Growing Telehealth Adoption:  The APAC region is witnessing a surge in telehealth adoption, driven by factors like increasing internet penetration and a shortage of healthcare professionals, particularly in rural areas. POC glucose testing devices that seamlessly integrate with telehealth platforms can empower patients in remote locations to receive timely consultations and guidance from healthcare providers.

Emphasis on Preventative Healthcare:  The growing awareness of the long-term complications associated with diabetes is shifting the focus towards preventative healthcare in the APAC region. POC glucose testing devices play a crucial role in enabling early detection of diabetes and promoting self-management practices, contributing to a preventative healthcare approach.

Challenges and Opportunities in the APAC Market:

Despite its immense potential, the APAC POC glucose testing market faces some challenges:

Uneven Healthcare Infrastructure: Healthcare infrastructure development varies considerably across the APAC region. While some countries boast advanced medical facilities, others struggle with limited resources and accessibility, particularly in rural areas. Addressing this disparity is crucial for ensuring equitable access to POC testing devices.

Limited Reimbursement Policies: Reimbursement policies for POC glucose testing devices can be complex and vary depending on individual countries and healthcare providers. Streamlining these policies could significantly increase patient access to these devices.

Inquire before buying: https://www.nextmsc.com/point-of-care-glucose-testing-market/inquire-before-buying

Looking Ahead: A Future of Innovation and Accessibility

The APAC region is on track to become a dominant force in the POC glucose testing market. With its large and growing diabetic population, rising disposable incomes, and increasing government support, the demand for these devices is expected to surge in the coming years. However, addressing the challenges of uneven healthcare infrastructure and limited reimbursement is crucial for ensuring equitable access and maximizing the impact of POC testing in the region. By fostering innovation in affordable and accessible technologies, coupled with improved healthcare infrastructure and supportive policies, the APAC region can leverage POC glucose testing devices to empower patients with diabetes and achieve better health outcomes.

Conclusion:

The APAC region stands poised to become a leader in the global point-of-care glucose testing market. Driven by a rapidly rising diabetic population, increasing disposable incomes, and supportive government initiatives, the demand for these devices is projected to soar. Several factors contribute to this growth, including a focus on affordable and accessible technologies, the integration with mobile health (mHealth) applications, and the rise of big data and AI for personalized diabetes management. Furthermore, the growing adoption of telehealth and the emphasis on preventative healthcare in the APAC region further incentivize the use of POC glucose testing devices. However, challenges remain. Uneven healthcare infrastructure and limited reimbursement policies can create barriers to access, particularly in rural areas. Addressing these disparities is crucial for maximizing the impact of POC testing and ensuring equitable access for all.

[adityarana1687-blog]

Biosensors Market Size To Reach $49.78 Billion By 2030

The global biosensors market size was estimated at USD 28.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. The key factors driving the industry growth include various applications in the healthcare/medical sector, increasing demand in the bioprocessing industry, and rapid technological advancements in drug screening due to the COVID-19 pandemic. Moreover, the pandemic led to the rapid expansion of the biosensor industry due to an increase in the number of hospitals worldwide.

Over the forecast period, technological advancements are expected to be significant growth drivers for the industry. For example, in January 2022, a U.S. medical device manufacturer, Abbott, launched a universal consumer wearable device with biosensors. The company announced the development of a new line of consumer biometric wearable devices called Lingo, designed for more general fitness and wellness purposes. In addition, increasing demand for biosensors and bioreactors for new drug development is likely to lead to industry expansion in the near future due to improved biosensor technology.

 Request a free sample copy or view report summary: Biosensors Market Report

Biosensors Market Report Highlights

The electrochemical biosensors technology segment accounted for the largest revenue share in 2023

The segment is anticipated to witness significant growth over the forecast period owing to the widespread applications for analysis & quantification in biochemical and biological processes

Based on the application, the medical segment dominated the industry in 2023. This device is considered an essential tool in the monitoring and detection of a wide range of medical conditions, such as cancer and diabetes

Middle East & Africa is expected to witness the fastest growth rate over the forecast period

This is owing to a rise in research & development activities and constantly improving healthcare facilities in the region.

Biosensors Market Segmentation

Grand View Research has segmented the biosensors market report on the basis of technology, application, end-user, and region:

Biosensors Technology Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

Thermal

Electrochemical

Piezoelectric

Optical

Biosensors Application Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

Medical

Cholesterol

Blood Glucose

Blood Gas Analyzer

Pregnancy Testing

Drug Discovery

Infectious Disease

Food Toxicity

Bioreactor

Agriculture

Environment

Others

Biosensors End-user Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

Home Healthcare Diagnostics

POC Testing

Food Industry

Research Laboratories

Security and Bio-Defense

Biosensors Regional Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Belgium

Switzerland

The Netherlands

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Indonesia

Thailand

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Turkey

Kuwait

List of Key Players of Biosensors Market

Bio-Rad Laboratories Inc.

Medtronic

Abbott Laboratories

Biosensors International Group, Ltd.

Pinnacle Technologies Inc.

Ercon, Inc.

DuPont Biosensor Materials

Johnson & Johnson

Koninklijke Philips N.V.

LifeScan, Inc.

QTL Biodetection LLC

Molecular Devices Corp.

Nova Biomedical

Molex LLC

TDK Corp.

Zimmer & Peacock AS

Siemens Healthcare

[spookysaladchaos]

Global Top 5 Companies Accounted for 77% of total POC HbA1C Testing market (QYResearch, 2021)

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

In this report, we mainly study the devices for POC HbA1C Testing without services.

According to the new market research report “Global POC HbA1C Testing  Market Report 2023-2029”, published by QYResearch, the global POC HbA1C Testing  market size is projected to reach USD 0.85 billion by 2029, at a CAGR of 7.8% during the forecast period.

Figure.   Global POC HbA1C Testing Market Size (US$ Million), 2018-2029

Figure.   Global POC HbA1C Testing Top 5 Players Ranking and Market Share（Based on data of 2021, Continually updated）

The global key manufacturers of POC HbA1C Testing  include Abbott, Siemens, Roche, Sinocare (PTS Diagnostics), Trinity Biotech, EKF Diagnostics, Bio-Rad, SD Biosensor, HUMAN Diagnostics, Erba Diagnostics, etc. In 2021, the global top five players had a share approximately 77.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

For more information, please contact the following e-mail address:

Email: global@qyresearch.com

Website: https://www.qyresearch.com

[researchreportinsight]

POC Blood Glucose Monitoring Devices Market Analysis, Growth, Share, Industry Trends, Supply Demand, Forecast and Sales to 2025

2 May 2019 - Global POC Blood Glucose Monitoring Devices Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. POC is abbreviated as point-of-care tests. POC blood glucose monitoring devices allow instant determination of glucose level in hospitalized patients and facilitate correct treatment decision.

The factors that are playing a major role in the growth of the market are the growing number of diabetic patients across the globe, the rising use of enhanced technologies, and the growing initiates to reduce the number of diabetic cases. However, the high cost of diabetes management may restrain overall market growth in the years to come. The market is segmented based on product type, end-user, and region.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/poc-blood-glucose-monitoring-devices-market

Instruments, consumables, and other product types could be explored in POC blood glucose monitoring devices market in the forecast period. The consumable sector accounted for the substantial market share of POC blood glucose monitoring devices and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the growing number of diabetic patients and blood glucose monitoring tests, and the growing demand for disposable consumables to prevent contamination.

The POC blood glucose monitoring device market could be categorized based on end-users like home care settings, hospitals and clinics, clinical diagnostic laboratories, and others that could be explored in POC blood glucose monitoring devices in the forecast period. The hospital and clinics sector accounted for the substantial market share of POC blood glucose monitoring devices and is estimated to continue its dominance in the years to come. The reason could be the increasing cases of hyperglycemia and diabetes.

Globally, North America accounted for the significant market share of POC blood glucose monitoring devices and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the growing number of diabetic cases in the United States, the presence of developed healthcare infrastructure, the presence of key manufacturers in the region, and the rising focus on enhanced technologies. In addition, the development of non-invasive wearable POC glucose monitoring devices may boost the overall market in the years to come. The United States is a major consumer of POC blood glucose monitoring devices in this region.

Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The developing countries like India and China are the major consumers of POC blood glucose monitoring devices in this region. The key players of POC blood glucose monitoring devices market are Johnson & Johnson, Abbott, F. Hoffmann-La Roche, ARKRAY, Danaher, and Ascensia Diabetes Care. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.

Market Segment:

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

• Abbott

• BD Medical

• Medtronic

• Sanofi

• Roche Diagnostics

• LifeScan

• Alere

• Animas Technologies

• Bayer Healthcare

• Cercacor

• Pendragon Medical

• OrSense

• Nova Biomedical

• Dexcom

• Terumo

• Tosoh Bioscience

Market size by Product

• Wearable Blood Glucose Monitoring Devices

• Non-wearable Blood Glucose Monitoring Devices

• Market size by End User

• Hospitals

• Clinics

• Home Care Settings

• Other

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/poc-blood-glucose-monitoring-devices-market/request-sample

[researchinhealthcare]

Test Strip Market 2021 – Global Industry Size, share, Business Insights, Growth Analysis, Recent Trends, Demands and Forecast By 2027

Test Strip Market Overview :

Test strip is a type of diagnostic devices which is the most important tools in Point of Care (POC) diagnostics. These test strip helps to achieve rapid diagnosis of various critical diseases such as urinary tract infection (UTI), liver disease, kidney diseases, diabetes test, ophthalmic disease and others with precsion.

Test strips are widely used for monitoring the blood glucose level in the diabetic patients. As per world Health Organization (WHO), it was estimated that in 2016, 420 million adult population is suffering from diabetes all over the world will and the number is expected to reach 625 million till 2040.

The global test strip market is growing with the dynamic pace. The global test strip market is expecting a sound growth at a CAGR of 12.8% during the forecasted period. Increasing prevalence of diabetes, and other urinary tract diseases has supported the growth of this market.

According to a recent study report published by the Market Research Future, The global test strip market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2021, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2021).

The market is expected grow with the same trends during the forecast period. The major drivers supporting the growth of the market will be presence of huge diabetic patient population in Asia Pacific region like India and China. According to WHO (2014), 60% of the world’s total diabetic population lives in Asia region.

Moreover, the global test strip market is driven by rising geriatric population, and rapid development in the test strips has driven the growth of the market. Moreover, changing lifestyle, and government initiatives for encouragement for the research & development has fuelled the market growth. On the other hand, availability of alternative methods for diagnosis like saliva collection devices has restrained the growth of global test strip market.

Test Strip Market Competitive Analysis :

The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market.

The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics among others are some of the small players that accounts a reasonable amount of share in the test strip market.  

Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/672

The global test strip market is highly fragmented with the presence of many local players and international players. As a result, local players are focus on cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through FDA approvals, collaborations to expand their overall market share.

For instance, Abbot a leading player in the test strip market has received US Food and Drug Administration (FDA) clearance for its new product FreeStyle Lite blood glucose test strips that minimizes the interference during blood glucose testing, hence is fabricated for a better testing experience. This will help Abbott to create an impact on the patient pool and will help to increase its sales by volume.

Hoffmann-La Roche Ltd, Swiss multinational healthcare company focuses on the development and distribution of test strips. For this, in June 2017, Roche has acquired mySugr to form a leading open platform for digital diabetes management. Hence, the growing mergers and acquisitions, new product launches in the field of test strip has upsurged the growth of the market.

Test Strip Industry Key Players :

Hoffmann-La Roche Ltd (Switzerland), Siemens Ltd. (Germany), Abbott (US), B. Braun (Germany), LifeScan, Inc. (US), Chiltern MediCare Ltd. (US), Henry Schein, Inc. (US), Lifeassay Diagnostics (South Africa), Siemens Healthcare Private Limited (Germany), ARKRAY Inc. (US), Ascensia Diabetes Care Holdings AG. (Switzerland), TaiDoc Technology Corporation (Taiwan), Teco Diagnostics (US) are some of the prominent players at the forefront of competition in the Global Test Strip Market and are profiled in MRFR Analysis.

Report Details @ https://www.marketresearchfuture.com/reports/test-strip-market-672 .

[clevertimetravelpaper]

Glucose Analysis Devices Market is projected to grow at a CAGR of 7.50% during the forecast period to 2029

A glucose analyzer is made up of three parts: a recognition element that identifies the target molecules, a transducer element that measures the signal from the target molecules, and a processing system that reads the signal. Glucose analyzer devices are used to screen for and control diabetes, by monitoring blood glucose levels. In sports medicine, it is also used to screen for momentary high or low glucose levels.

Data Bridge Market Research analyses that the glucose analyzer devices market which was USD 12.45 billion in 2021, would rocket up to USD 22.20 billion by 2029, and is expected to undergo a CAGR of 7.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Sample PDF of the Report –   https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-glucose-analyzer-devices-market

This Glucose Testing Devices Market report provides details about recent new developments, trade regulations, import and export analysis, production analysis, value chain optimization, market share, impact of national and localized market players, analyzes opportunities in terms of emerging revenue pockets, market changes regulations, strategic market growth analysis, market size, category market growth , niches and application dominance, product approvals, product launches, geographic expansions, technological innovations in the market.To get more insights on the Glucose Analyzer Market, contact us for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Market Scope and Market Size of Glucose Analysis Devices

The glucose analyzer market is segmented on the basis of product type, sample, and end user. The growth among these segments will help you analyze low growth segments within the industries and provide users with valuable market insight and market insights to help them make strategic decisions for identification of major market applications.

On the basis of product type, the glucose testing devices market is segmented into portable POC glucose analyzer and benchtop POC glucose analyzer

On the basis of sample, the glucose testing devices market is segmented into  blood  and saliva

The glucose analyzer market is also segmented on the basis of end user into  hospitals , offices, home care, clinics, outpatient surgery centers, and others.

To get more insights into Market Analysis, browse Research Report Summary @-  https://www.databridgemarketresearch.com/reports/global-glucose-analyzer-devices-market

Country Level Analysis of the Glucose Analysis Devices Market 

The Glucose Analysis Devices Market is analyzed and market size insights and trends are provided by country, product type, sample and end-user as listed above. The countries covered in the report are USA, Canada and Mexico in North America, Germany, France, UK, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan,  India and South Korea. , Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of Middle East and Africa (MEA), Brazil, Argentina, and Rest of South America as part of South America.

Asia-Pacific dominates the glucose analyzer market due to large number of underserved populations and low awareness about their medical conditions, which is driving the market growth in this region.

The country section of the Glucose Analyzer market report also provides individual market impacting factors and regulatory changes in the country market that impact current and future market trends. Data points such as consumption volumes, production sites and volumes, import and export analysis, price trend analysis, raw material cost, value chain analysis Downstream and Upstream are some of the major indicators used to forecast the market scenario for each country.In addition, the presence and availability of global brands and the challenges they face due to significant or rare competition from local and national brands, the impact of domestic tariffs and trade routes are considered while providing a forecast analysis of national data.

Competitive Landscape and Glucose Testing Devices Market Share Analysis

Glucose Analyzers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, research and development investment, new market initiatives, global presence, locations and production facilities, production capacities, company strengths and weaknesses, product launch, product breadth and breadth, application dominance. The data points above provided are only related to the companies focus on the glucose testing devices market.

Key players covered in the Glucose Analyzer market report are Cardinal Health, Eurotrol BV, Messe Düsseldorf GmbH, Messe Düsseldorf GmbH, Abbott, Diasys Diagnostics India Private Limited, Siemens Healthineers AG, McKesson Corporation, Universal Biosensors, i-SENS , Inc. , Bayer AG, ARKRAY, Inc, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Medtronic, Terumo Medical Corporation among other national and global players. Market share data is available separately for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America . DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Complete TOC at- https://www.databridgemarketresearch.com/toc/?dbmr=global-glucose-analyzer-devices-market

Top Healthcare Report Links:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

[mrfrblogresearch02]

Point of Care Diagnostics/Testing Market Demand, Cost Analysis And Latest Advancement in Medical Sector 2027

Market Highlights:

According to MRFR analysis, the global point of care diagnostics/testing Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The global point of care diagnostics/testing market is driven by several factors, such as increasing demand for remote diagnosis, rising demand for early-stage diagnosis products, and growing demand for minimally or non-invasive diagnostic products. Other factors such as the introduction of mobile healthcare technologies and wearable diagnostic devices, the emergence of new technologies for monitoring and imaging are creating opportunities for the market players.

The market players are involved in various strategic collaborations, mergers & acquisitions, product launches, cooperative development of the product, and investing in stock to expand their worldwide presence. For instance, in July 2020, Becton, Dickinson and Company (US) launched a rapid POC antigen test to diagnose SARS-CoV-2 in 15 minutes. In June 2020, Celltrion Group (South Korea) announced to launch COVID-19 POC antigen testing kit. Furthermore, the prominent players focus on employee satisfaction, transforming their research utilities, and diversifying their distribution network. These factors will augment the market growth and will increase the market share during the forecast period. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: North America is estimated to dominate the point of care diagnostics/testing market, owing to the increasing demand for virtual and convenient diagnostic solutions, enhancement in healthcare regulations, and growing awareness about wellness and healthcare among the young population. Furthermore, the involvement/adoption of strategies like mergers & acquisitions by key players, government partnerships, and the development of new products are also propelling the market growth. Europe embraces the second-largest position in the point of care diagnostics/testing market due to the increasing number of IVD testing, molecular diagnostics, and the prevalence of respiratory diseases across the region. The industry players are involved in various business activities such as product launches, mergers and acquisitions, partnerships, and other commercial approaches. For instance, in May 2020, ProciseDx (US) launched 510k filing for CRP test in Europe for gastrointestinal disorders. The product launch aims to offer high lab-quality results to the patients. In addition, in July 2021, QuantuMDx (Singapore) launched Q-POC, a point-of-care diagnostics to detect SARS-CoV-2. The product is easy to use, affordable, and offers results in 30 minutes. Such business parameters are expected to propel the point of care diagnostic market in the forecast period.

Asia-Pacific is projected to be the fastest-growing regional market during the study period due to increasing demand for diagnostic tests such as blood gas tests, rapid blood coagulation tests, pregnancy tests, drug abuse screening, rapid diagnosis of cardiac markers, blood glucose testing, electrolyte analysis, urine analysis, and dry biochemical tests across the region. In addition, the increasing demand for multiple diagnostic devices coupled with the rising demand for accurate and efficient diagnostic and testing devices is driving the Asia-Pacific point of care diagnostics market.

The growth of the market in the Rest of the World is gaining importance over the last few years due to the increasing diagnosis of HbA1c and growing demand for glycated hemoglobin analysis. Moreover, the rising number of COVID-19 cases across the region is supporting the demand for POCs diagnosis. In addition, increasing investment in healthcare device manufacturing facilities is strengthening the product portfolio of the regional and global healthcare providers. The escalating demand for in-vitro diagnostics in South America is fueling the sales of POCs across the region. Such factors are expected to augment the market growth over the assessment period.

Segmentation:

The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[industry365]

Biosensors Market Is Expected To Reach New Growth Revenues During 2021-2028

The global biosensors market size is expected to reach USD 40.53 billion by 2028 according to a new study by Polaris Market Research. The report “Biosensors Market Share, Size, Trends, Industry Analysis Report, By Technology (Thermal, Electrochemical, Piezoelectric, Optical); By Application; By End-Use; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into the current market dynamics and provides analysis on future market growth.

The introduction of nanotechnology-based biosensors, usage of instruments in blood sugar level monitoring in diabetes patients, increasing demand for home-based point-of-care devices due to the COVID-19 pandemic, increasing advancement in technology, and mounting government policies toward diagnostics are some of the significant factors that may complement the global industry development.

Several new technologies have been developed in recent years which will revolutionize biosensor technology. Nano-biosensors have emerged in recent years, and they are increasingly used in various genomics and proteomic techniques.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:  https://www.polarismarketresearch.com/industry-analysis/biosensors-market/request-for-sample

The wide application of the product in the medical field will drive the growth of the industry. It is used in various medical section, including drug discovery, blood gas analyzer, cholesterol checking, infectious diseases, and blood glucose monitoring. Such devices are an essential tool in detecting several conditions, from diabetes to cancer, and thus contribute to industry growth.

There are several developments in the global industry in recent times due to its popularity and increased adoption. Fox BIOSYSTEMS launched a white Fox biosensor in March 2021. The biosensor is developed to overcome clogging in samples such as whole blood or lysates. It can detect microvesicles, nanobodies, antibodies, phage, and small molecules, and the probe in this biosensor is based on generic surface chemistry.

The COVID-19 pandemic is expected to further drive the growth of the global industry during the forecast period owing to the adaptation of the product in COVID-19 diagnosis and monitoring. Various companies are developing new COVID-19 associated products at different development levels, and these products are soon expected to be launched in the industry.

Market Participants such as Abbott Laboratories, Bayer AG, AZUR Environmental, Biosensor BV, DuPont Biosensor Materials, Cranfield Biotechnology Centre, Pinnacle Technologies Inc., Johnson & Johnson, Ercon, Inc., EG & IC Sensors, Inc., Strategic Diagnostics, Innovative Biosensors Inc., Sysmex Corporation, LifeScan, Inc., QTL Biosystems, Molecular Devices Corp., and Roche Diagnostics are some of the key players operating in the global market.

Get Discount offer: https://www.polarismarketresearch.com/industry-analysis/biosensors-market/request-for-discount-pricing

Polaris Market Research has segmented the biosensors market report on the basis of product, application, end-use, and region:

Biosensors, Technology Outlook (Revenue – USD Million, 2016 – 2028)

Thermal

Electrochemical

Piezoelectric

Optical

Biosensors, Application Outlook (Revenue – USD Million, 2016 – 2028)

Medical

Food Toxicity

Bioreactor

Agriculture

Environment

Others

Cholesterol

Blood Glucose

Blood Gas Analyzer

Pregnancy Testing

Infectious Testing

Biosensors, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

Home Healthcare Diagnostics

POC Testing

Food Industry

Research Laboratories

Security and Biodefense

Biosensors Market, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

UK

France

Italy

Spain

Austria

Netherlands

China

India

Japan

South Korea

Malaysia

Indonesia

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

UAE

Israel

Buy Now: https://www.polarismarketresearch.com/checkouts/9031

[healthcare-market]

Hemoglobin A1c Testing Market Size, Share, Growth Trends, and Forecast Analysis

Transparency Market Research (TMR) has published a new report titled, ‘Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Hemoglobin A1c Testing Devices market was valued at US$ 1,676.3 Mn in 2018 and is projected to expand at a CAGR of 10.7% from 2019 to 2027.

Overview

· Hemoglobin A1c testing devices are used to determine and monitor hemoglobin A1c levels in diabetic patients. For more than 500 million people affected with diabetes across the world, blood testing has become a routine part of managing the disease. A1C tests measure average blood glucose over the past two to three months. It is also known as glycosylated hemoglobin test, glycohemoglobin test, glycated hemoglobin test, or A1C.

· In terms of technology, ion-exchange HPLC segment dominated the market owing to the establishment of this technology as gold standard method of determination of HbA1c due to its excellent specificity and reproducibility. A clinical study by the company indicated that 205 patients with SC and diabetes were analyzed using immunoassay and HPLC instrument. The immunoassay study produced lower HBA1c compared to HPLC method.

· In terms of end-user, hemoglobin A1c testing devices are mostly used in laboratories and point-of-care units such as hospitals, clinics, home care, and others.

· North America dominated the global Hemoglobin A1c Testing Devices market in 2018 and the trend is anticipated to continue during the forecast period. High prevalence of different types of diabetes and rise in the geriatric population in the region are some of the factors augmenting the market in North America are expected to drive the market in North America.

· Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast period

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73900

Recent approval of HBA1C tests in year 2018 to Drive Market

· A1CNow systems developed by PTS Diagnostics got approved in year 2018 which provides accurate A1C results in the office or home comes in a convenient 2-test pack or 4-test pack.

· Abbott laboratories got its Afinion assay product approved which is the first-ever rapid point-of-care test approved to help diagnose diabetes and assess patients’ risk of developing the disease

· Bio-Rad Laboratories, Inc product VARIANT II System got its approval which offers fully automated high-volume hemoglobin A1c and β-thalassemia testing, with Clinical Data Management Software and a LIS interface.

Faster adoption and Increase in point-of-care testing to Drive Market

· Point-of-care testing provides results within time limit, offers consumer convenience, reduces needle stick injuries, and minimizes contamination

· It has also led to development of the smaller devices, portable, and minimally invasive product. Hence, several laboratories are being converted into POC testing laboratories, as these can be operated by person not necessarily biologist. POC laboratories are also considered an easy way of providing clinical microbiology testing for people far away from core laboratories in developed and developing countries

Ion-exchange HPLC Segment to Dominate Market

· Based on technology, the global Hemoglobin A1c Testing Devices market has been divided into Ion-exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, and others. The Ion-exchange HPLC, dominates the market in year 2018, owing to the excellent specificity and reproducibility, and ability to detect the most common Hb variants through HPLC. According to Bio-Rad Laboratories, Inc., the American Diabetes Association (ADA) recommends HbA1c equal to or more than 6.5% to diagnose diabetes using HPLC. ADA considers HPLC as the gold standard method for the determination of HbA1c.

· However, cost of HbA1c treatment using HPLC method compared to other techniques is high, which is likely to induce patients to adopt other techniques.

Request for Analysis of COVID19 Impact on Hemoglobin A1c Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73900

Point-of-care settings to be Highly Lucrative Segment

· In terms of end-user, the global Hemoglobin A1c Testing Devices market has been classified into laboratories, and point-of-care settings.

· The laboratories segment dominated the Hemoglobin A1c Testing Devices market owing to rise in the number of cases of diabetes type II disorders, enhanced diagnostic care services, and availability of a wide range of services at a single site in commercial laboratories. However, rise in diagnostic costs and changes in reimbursement models are estimated to hamper the segment during the forecast period.

· The point-of-care settings segment expected to expand at faster pace during forecast period. According to the American Diabetes Association, point-of-care (POC) testing for HbA1c to offers the opportunity for more timely treatment changes. The International Diabetes Federation (IDF) recommends determination of HbA1c either at the POC or in the laboratory should be done before clinical consultation.

North America to Dominate Global Market

· In terms of region, the global Hemoglobin A1c Testing Devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Hemoglobin A1c Testing Devices market in 2018, followed by Europe.

· North America accounted for major share of the global Hemoglobin A1c Testing Devices market in 2018, owing to increase in demand for direct enzyme assay techniques; technological advancements in HPLC technology; and rise in the adoption of various chromatographic devices by hospitals, diagnostic labs, and clinics are likely to propel the market in the region during the forecast period

· The Hemoglobin A1c Testing Devices market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to increasing population in the region, unmet medical needs, rise in prevalence and incidence of diabetes diseases are some of the factors expected to drive the hemoglobin A1c testing devices market in Asia Pacific during the forecast period. Moreover, development in the field of science, high disposable income, and rise in per capita health care expenditure propel the market in the region.

Buy now Hemoglobin A1c Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=73900&ltype=S

Competitive Landscape

· The global Hemoglobin A1c Testing Devices market is fragmented in terms of number of players. Key players in the global market include Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, Trinity Biotech plc. and other prominent players.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/global-corneal-topographers-market-is-likely-to-be-driven-by-high-prevalence-of-diabetes-and-rise-in-aging-population-tmr-301237312.html

https://www.prnewswire.co.uk/news-releases/rising-sales-of-indwelling-voice-prostheses-spurs-growth-momentum-of-voice-prosthesis-devices-market-m-amp-a-activities-key-strategy-for-consolidation-tmr-862220741.html

https://www.prnewswire.com/news-releases/novel-use-to-treat-patients-of-covid-19-to-expand-horizon-of-blood-purification-equipment-market-swift-fda-approvals-for-emergency-use-attract-players-for-product-innovation-tmr-301244584.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

[reportsjournal]

Primary Care POC Diagnostics Market Players, Trends & Forecast, 2021–2028

The report has been gathered by making use of both primary and secondary research methodologies. The report analyzes the Primary Care POC Diagnostics Market on the basis of manufacturing and consumption prospects, so as to provide a thorough industry structure overview to the readers. In terms of its production capacity, the global market research report surveys the production, gross margin of its leading service providers, revenue, and/or unit price that they offer in different countries/regions since a previous couple of years.

Furthermore, the report covers various important aspects of the industry such current and emerging trends, updated outlines, growth factors, restraints, growth prospects and opportunities, regulatory framework and government policies, macro and micro economic factors, and other factors that enable to draw projections for the estimated market growth in the forecast period. Key companies in the Primary Care POC Diagnostics market include: Roche Diagnostics, BD Biosciences, Danaher Corporation, Abbott Laboratories, Instrumentation Laboratory, bioMerieux, Siemens Healthcare, and Quidel Corporation.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4097 For the purpose of this report, Reports and Data has segmented the global primary care POC diagnostics market on the basis of product, end use and region:

Product Outlook (Revenue, USD Billion; 2018 – 2028)

Glucose Testing

Hb1Ac Testing

Coagulation

Fertility

Infectious Diseases

Cardiac Markers

Thyroid Stimulating Hormone

Haematology

Primary Care Systems

Decentralized Clinical Chemistry

Faeces

Lipid Testing

Cancer Marker

Blood Gas/Electrolytes

Ambulatory Chemistry

Drug Abuse Testing

Urinalysis

By End Use Outlook (Revenue, USD Billion; 2018 – 2028)

Pharmacy & Retail Clinics

Physician Office

Urgent Care Clinics

Non-practice Clinics

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/primary-care-poc-diagnostics-market

Some Key Highlights in the Report:

The glucose testing segment accounted for largest market share in     2020. Increasing adoption of glucose monitoring devices, expanding diabetic     population, and growing awareness about keeping glucose level in check are     factors that will drive the segment’s revenue growth.

The physician’s office segment accounted for largest revenue share     among the end use segments in 2020.

Pharmacy and retail clinics segment is expected to be another     fastest-growing segment. This growth is due to increase in the number of     patients needing chronic disease tests at pharmacies and the availability     of point-of-care testing at pharmacies and retail clinics.

Market revenue from North America primary care POC diagnostics     market is expected to grow at a significantly high rate over the forecast     period due to presence of major market players in the region offering     better tools for primary care settings.

Asia Pacific region is expected to hold considerable revenue share     due to initiatives taken in various governments for better access to     primary care and integration of POC diagnostics into primary care     settings.

What questions does the Primary Care POC Diagnostics market report answer pertaining to the regional reach of the industry?

1.       The report claims to split the regional scope of the Primary Care POC Diagnostics market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration?

2.       How do the sales figures look at present how does the sales scenario look for the future?

3.       Considering the present scenario, how much revenue will each region attain by the end of the forecast period?

4.       How much is the growth rate that each topography will depict over the predicted timeline?

Speak to analyst@ https://www.reportsanddata.com/speak-to-analyst-form/4088 Thank you for reading our report. For further inquiry, please get in touch with us. Our team will ensure the report is customized to meet your requirements.

[adityarana1687-blog]

Biosensors Market Is Expected To Grow Swiftly By 2030

The global biosensors market size was estimated at USD 28.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. The key factors driving the industry growth include various applications in the healthcare/medical sector, increasing demand in the bioprocessing industry, and rapid technological advancements in drug screening due to the COVID-19 pandemic. Moreover, the pandemic led to the rapid expansion of the biosensor industry due to an increase in the number of hospitals worldwide.

Over the forecast period, technological advancements are expected to be significant growth drivers for the industry. For example, in January 2022, a U.S. medical device manufacturer, Abbott, launched a universal consumer wearable device with biosensors. The company announced the development of a new line of consumer biometric wearable devices called Lingo, designed for more general fitness and wellness purposes. In addition, increasing demand for biosensors and bioreactors for new drug development is likely to lead to industry expansion in the near future due to improved biosensor technology.

Request a free sample copy or view report summary: Biosensors Market Report

Biosensors Market Report Highlights

The electrochemical biosensors technology segment accounted for the largest revenue share in 2023

The segment is anticipated to witness significant growth over the forecast period owing to the widespread applications for analysis & quantification in biochemical and biological processes

Based on the application, the medical segment dominated the industry in 2023. This device is considered an essential tool in the monitoring and detection of a wide range of medical conditions, such as cancer and diabetes

Middle East & Africa is expected to witness the fastest growth rate over the forecast period

This is owing to a rise in research & development activities and constantly improving healthcare facilities in the region.

Biosensors Market Segmentation

Grand View Research has segmented the biosensors market report on the basis of technology, application, end-user, and region:

Biosensors Technology Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

Thermal

Electrochemical

Piezoelectric

Optical

Biosensors Application Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

Medical

Cholesterol

Blood Glucose

Blood Gas Analyzer

Pregnancy Testing

Drug Discovery

Infectious Disease

Food Toxicity

Bioreactor

Agriculture

Environment

Others

Biosensors End-user Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

Home Healthcare Diagnostics

POC Testing

Food Industry

Research Laboratories

Security and Bio-Defense

Biosensors Regional Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Belgium

Switzerland

The Netherlands

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Indonesia

Thailand

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Turkey

Kuwait

List of Key Players of Biosensors Market

Bio-Rad Laboratories Inc.

Medtronic

Abbott Laboratories

Biosensors International Group, Ltd.

Pinnacle Technologies Inc.

Ercon, Inc.

DuPont Biosensor Materials

Johnson & Johnson

Koninklijke Philips N.V.

LifeScan, Inc.

QTL Biodetection LLC

Molecular Devices Corp.

Nova Biomedical

Molex LLC

TDK Corp.

Zimmer & Peacock AS

[healthcaremarkettrend]

Over The Counter Test Market: Invasiveness of Blood Glucose Monitors

[96 Pages Report] The OTC tests market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period.

The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178 By product type, infectious disease tests are expected to be the fastest-growing segment in the OTC Test market during the forecast period.

The infectious disease tests segment is projected to grow at the highest CAGR between 2018 and 2024. Growth in this market can be attributed to factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China.

By technology, the lateral flow assays segment is growing at the highest rate.

The lateral flow assays segment is projected to grow at the highest rate in the OTC Test Market, by technology. In the past few years, the lateral flow assay POC testing market has grown significantly due to the increasing adoption of LFA testing products in home care. Companies are increasingly focusing on the development of innovative LFA-based OTC devices for the confirmation of pregnancy (using hCG levels) and ovulation, screening for infectious diseases and drugs of abuse are the factors expected to drive the growth of these markets during the forecast period

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=78819178

The Over the Counter Test Market in the Asia Pacific is growing at the highest CAGR during the forecast period.

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The high growth in this regional segment is majorly attributed to the increasing patient population base and the growing prevalence of infectious diseases.

Key Over The Counter Test Market Players: The key players operating in the global Over The Counter Test Market are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the OTC tests market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst